Navigation Links
Thoratec Presentation at Raymond James Conference to Be Webcast
Date:3/3/2009

PLEASANTON, Calif., March 3 /PRNewswire-FirstCall/ -- Thoratec Corporation (Nasdaq: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today that it will be participating in the Raymond James 30th Annual Institutional Investors Conference on Monday, March 9.

David Smith, executive vice president and chief financial officer, will provide an update on the company, beginning at 8:05 a.m., Eastern Daylight Time, (5:05 a.m., Pacific Daylight Time).

The presentation will be available through the conference website at http://www.wsw.com/webcast/rj43/thor/ or on the company's website at http://www.thoratec.com.

Thoratec is a world leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) VAD (Ventricular Assist Device) and HeartMate(R) LVAS (Left Ventricular Assist System) with more than 12,000 devices implanted in patients suffering from heart failure. Additionally, its International Technidyne Corporation (ITC) division supplies point-of-care blood testing and skin incision products. Thoratec is headquartered in Pleasanton, California. For more information, visit the company's web sites at http://www.thoratec.com or http://www.itcmed.com.


'/>"/>
SOURCE Thoratec Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Thoratec Announces Definitive Agreement to Acquire HeartWare International For US$282 Million;
2. Thoratec Reports 34 Percent Increase in 2008 Revenues
3. Thoratec Schedules Fiscal 2008 Year-End Conference Call, Webcast
4. Thoratec Presentation at Piper Jaffary Conference to be Webcast
5. Thoratec Reports 44 Percent Increase in Second Quarter Revenues;
6. Thoratec Schedules Second Quarter 2008 Conference Call, Webcast
7. Thoratec Schedules First Quarter 2008 Conference Call, Webcast
8. Thoratec Announces Unanimous FDA Advisory Panel Recommendation for Approval of HeartMate II(R) for Bridge-to-Transplantation
9. URGENT Thoratec Corporation Worldwide Recall of Implantable Ventricular Assist Device
10. Thoratecs ITC Division Receives FDA Warning Letter
11. Thoratec Schedules Third Quarter Conference Call, Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... 2017 , ... Bio-Optronics Inc. is proud to announce the ... to seamlessly integrate and streamline the way researchers prepare and conduct patient visits. ... and improving efficiency significantly for users – a first in the CTMS industry. ...
(Date:1/19/2017)... ... 2017 , ... Ultimate Medical Academy (UMA) is preparing to ... making a difference in the lives of the next generation of healthcare professionals. ... educational institution, has more than 30,000 alumni and employs more than 2,000 professionals. ...
(Date:1/19/2017)... , ... January 19, 2017 , ... ... insurance agency which serves Lawrenceville, New Jersey and the surrounding area, is ... Amyotrophic lateral sclerosis (ALS), more commonly known as Lou Gehrig's disease or motor ...
(Date:1/19/2017)... ... January 18, 2017 , ... The CHP suggests that California drivers can avoid ... slowing down and increasing the space between themselves and other vehicles, according to a ... attorney Raymond R. Hassanlou notes that, rain or shine, drivers should always incorporate safe ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... that will simplify the editing process for all media productions," said Christina Austin ... package of 30 simplistically styled self-animating paragraphs designed for multi-lined text purposes. ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... Massachusetts , January 19, 2017 ... ) announced that the U.S. Food and Drug Administration ... of a New Drug Application (NDA) for SHP465, a ... evaluated as a potential once-daily treatment for Attention-Deficit/Hyperactivity Disorder ... on or around June 20, 2017, the designated Prescription ...
(Date:1/19/2017)... Florida , January 19, 2017 ... Trump administration appears serious about reducing the FDA,s ... and innovation in the medical drug industry, many ... ahead with new clinical trials and development of ... companies forging ahead with recent developments include:  Moleculin ...
(Date:1/19/2017)... LONDON , Jan. 18, 2017 The ... provides understanding and access to partnering deals and agreements ... - Trends in partnering deals - Top deals by ... stage of development, technology type The report provides ... entered into by the world,s leading healthcare companies. ...
Breaking Medicine Technology: